<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">While SARS is no longer circulating, MERS should be suspected in individuals with a compatible febrile illness and an epidemiological risk factor [
 <xref ref-type="bibr" rid="CR128">128</xref>]. Risk factors include travel to the Arabian Peninsula or contact with a confirmed or suspected case within 14Â days of symptom onset. Patients under evaluation for MERS require isolation and implementation of standard, airborne, and contact precautions. Confirmatory testing and infection control should be coordinated through local or state health authorities. MERS may be confirmed in designated public health laboratories by RT-PCR testing of lower respiratory tract specimens [
 <xref ref-type="bibr" rid="CR129">129</xref>]. Multiple other specimen types including upper respiratory tract samples, serum, and stool should also be collected for testing. Serologic testing can be used to evaluate for suspected infection among individuals no longer shedding virus [
 <xref ref-type="bibr" rid="CR129">129</xref>, 
 <xref ref-type="bibr" rid="CR130">130</xref>].
</p>
